Use of the Second Revision of the International Staging System for prognostic stratification of multiple myeloma patients in real-world clinical practice and the importance of sub-groups, including age

• Yuka Uesugi,
• Daisuke Ikeda,
• Ami Fukumoto,
• Rikako Tabata,
• Daisuke Miura,
• Kentaro Narita,
• Masami Takeuchi,
• Kosei Matsue

Affiliations

Yuka Uesugi

Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba

Daisuke Ikeda

Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba

Ami Fukumoto

Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba

Rikako Tabata

Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba

Daisuke Miura

Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba

Kentaro Narita

Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba

Masami Takeuchi

Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba

Kosei Matsue

Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba